Mirae Asset Global Investments Co., Ltd. Ultragenyx Pharmaceutical Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,482 shares of RARE stock, worth $145,172. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,482
Previous 230,767
98.92%
Holding current value
$145,172
Previous $10.8 Million
99.05%
% of portfolio
0.0%
Previous 0.02%
Shares
21 transactions
Others Institutions Holding RARE
# of Institutions
287Shares Held
88.1MCall Options Held
505KPut Options Held
198K-
Vanguard Group Inc Valley Forge, PA9.78MShares$572 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$328 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.35MShares$313 Million0.68% of portfolio
-
Wellington Management Group LLP Boston, MA4.56MShares$266 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$191 Million2.24% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $4.1B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...